Patents by Inventor Sara Pai

Sara Pai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease
    Publication number: 20230149347
    Abstract: The present invention relates to methods and compositions for treating human papilloma virus (HPV)-associated diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for treating immune checkpoint blockade resistant diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for enhancing the immune response against an HPV-associated disease using an inhibitor of CXCL12 signaling.
    Type: Application
    Filed: January 4, 2023
    Publication date: May 18, 2023
    Inventors: Mark C. Poznansky, Jeffrey A. Gelfand, Sara Pai
  • CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease
    Patent number: 11547694
    Abstract: The present invention relates to methods and compositions for treating human papilloma virus (HPV)-associated diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for treating immune checkpoint blockade resistant diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for enhancing the immune response against an HPV-associated disease using an inhibitor of CXCL12 signaling.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: January 10, 2023
    Assignee: The General Hospital Corporation
    Inventors: Mark C. Poznansky, Jeffrey Gelfand, Sara Pai
  • CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease
    Publication number: 20200030286
    Abstract: The present invention relates to methods and compositions for treating human papilloma virus (HPV)-associated diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for treating immune checkpoint blockade resistant diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for enhancing the immune response against an HPV-associated disease using an inhibitor of CXCL12 signaling.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 30, 2020
    Inventors: Mark C. Poznansky, Jeffrey Gelfand, Sara Pai